Skip to content

Author

Ai Kusakabe

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

A New Era of Treatment Sequencing in Platinum-Resistant Ovarian Cancer: Integrating Immunotherapy, Antibody–Drug Conjugates, and Targeted Therapies

Simple Summary Platinum-resistant ovarian cancer (PROC) is no longer managed only with sequential single-agent chemotherapy. Randomized phase III trials now support pembrolizumab plus weekly paclitaxel with or without bevacizumab, mirvetuximab soravtansine for FRα-high disease, and relacorilant plus nab-paclitaxel, whi...

Seiji Mabuchi, Ai Kusakabe, Y. Takimoto · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.